These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 6144790

  • 1. Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
    Martin GE, Bendesky RJ.
    J Pharmacol Exp Ther; 1984 Jun; 229(3):706-11. PubMed ID: 6144790
    [Abstract] [Full Text] [Related]

  • 2. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
    Shannon HE, Peters SC.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
    [Abstract] [Full Text] [Related]

  • 5. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD, Harting J, Minck KO.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [Abstract] [Full Text] [Related]

  • 6. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE, Haubrich DR, Williams M.
    Eur J Pharmacol; 1981 Nov 19; 76(1):15-23. PubMed ID: 7318920
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
    Ackerman JM, Johansen PA, Clark D, White FJ.
    J Pharmacol Exp Ther; 1993 May 19; 265(2):963-70. PubMed ID: 8098768
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.
    Jackson DM, Ross SB, Edwards SR.
    J Neural Transm; 1989 May 19; 75(3):213-20. PubMed ID: 2784489
    [Abstract] [Full Text] [Related]

  • 10. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.
    Woolverton WL, Goldberg LI, Ginos JZ.
    J Pharmacol Exp Ther; 1984 Sep 19; 230(3):678-83. PubMed ID: 6332190
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors.
    Andén NE, Grabowska-Andén M.
    Acta Physiol Scand; 1988 Oct 19; 134(2):285-90. PubMed ID: 2852446
    [Abstract] [Full Text] [Related]

  • 12. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E, Tonello C, Imhof R, Scherschlicht R, da Prada M, Carruba MO.
    J Pharmacol Exp Ther; 1993 Jul 19; 266(1):97-105. PubMed ID: 8101225
    [Abstract] [Full Text] [Related]

  • 13. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J, Briley M, Langer SZ.
    Eur J Pharmacol; 1983 Mar 18; 88(1):11-26. PubMed ID: 6133762
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Nov 18; 267(2):765-75. PubMed ID: 7902432
    [Abstract] [Full Text] [Related]

  • 16. Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
    Martin GE, Williams M, Pettibone DJ, Zrada MM, Lotti VJ, Taylor DA, Jones JH.
    J Pharmacol Exp Ther; 1985 May 18; 233(2):395-401. PubMed ID: 2987478
    [Abstract] [Full Text] [Related]

  • 17. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L, Pitts DK.
    J Pharmacol Exp Ther; 1995 Jan 18; 272(1):164-76. PubMed ID: 7815330
    [Abstract] [Full Text] [Related]

  • 18. The search for selective dopaminergic autoreceptor agonists.
    Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A, Nilsson JL.
    J Neural Transm Suppl; 1983 Jan 18; 18():131-7. PubMed ID: 6576112
    [Abstract] [Full Text] [Related]

  • 19. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.
    Williams M, Martin GE, McClure DE, Baldwin JJ, Watling KJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec 18; 324(4):275-80. PubMed ID: 6141532
    [Abstract] [Full Text] [Related]

  • 20. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C, Abraini JH, David HN.
    Hippocampus; 2007 Dec 18; 17(11):1028-36. PubMed ID: 17604350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.